CA-CALDERA-MEDICAL
27.6.2024 15:01:29 CEST | Business Wire | Press release
Caldera Medical, a global leader in women’s pelvic health, is proud to announce its sponsorship of the Cynisca Cycling team. This partnership reflects Caldera Medical’s unwavering commitment to advancing women’s health and empowerment through sports and community engagement.
Cynisca Cycling, an elite women's professional cycling team, is dedicated to elevating female athletes and promoting gender equality in sports. The collaboration with Caldera Medical, renowned for its humanitarian efforts in women's health, is poised to drive significant impact in both the sporting and healthcare arenas.
“We’re extremely pleased to share this new development between our team and Caldera Medical,” commented Robin Farina, Cynisca operations and performance director. “Just like Cynisca, Caldera has made a commitment to advancing women. Through our collaboration, we’ll continue to support women both on and off the bike.”
“Our sponsorship of Cynisca Cycling aligns perfectly with Caldera Medical’s mission to enhance the quality of life for women around the world,” said Bryon Merade, CEO of Caldera Medical. “We believe that empowering women in sports contributes to their overall well-being and health. By supporting Cynisca Cycling, we aim to underscore the importance of physical activity, resilience, and community for women's health.”
Caldera Medical’s involvement with Cynisca Cycling will include:
Health and Wellness Workshops: Organizing workshops focused on pelvic health, mental wellness, and overall physical health for the athletes and their communities.
Awareness Campaigns: Launching joint campaigns to educate the public about women's health issues and the importance of regular check-ups and active lifestyles.
Community Engagement: Participating in community events and activities that promote women's health and empowerment.
This sponsorship represents a significant step in Caldera Medical’s broader mission to address and improve women's health globally. The partnership with Cynisca Cycling will provide a dynamic platform to promote health, fitness, and empowerment among women, resonating with Caldera’s core values of compassion, excellence, and innovation.
About Caldera Medical
Caldera Medical is a medical device company solely focused on women’s health with a commitment to our mission of “Improving the Quality of Life for Women!” Caldera Medical develops, manufactures and markets best-in-class surgical products for the treatment of Stress Urinary Incontinence, Pelvic Organ Prolapse Polyps and Fibroids.
Caldera Medical forms close relationships with surgeons and continues to build the company around a principle of customer intimacy. In partnership with its surgeon customers, Caldera Medical has the largest humanitarian program of any women’s health company. It is committed to treating one million women in underserved populations around the world by the year 2027.
About Cynisca Cycling
Cynisca Cycling is a UCI-registered Women’s Continental Team (CYN-USA), dedicated to providing inspiration and support for women to reach the highest levels in cycling - both on and off the bike. The team provides professional support and guidance around a select racing program at the top European and U.S. events.
Launched in 2022 in partnership with USA Cycling, the team began racing in 2023 with an international roster now featuring twelve select North American riders who hold three national titles and a Pan American championship title. Other countries represented include France, Ireland, and Canada. Cynisca is committed to fair pay for female athletes and to providing employment opportunities for women.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240627021263/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Hexagon Semi’s HX77 AR Display Processor Achieves Ultra-Low Power Consumption with VeriSilicon’s Nano IP Portfolio10.3.2026 01:00:00 CET | Press release
VeriSilicon’s Mature GPU, Display Processing, and DeWarp IPs Collaboratively EnableHighlyIntegrated, Low-Latency AR Display Processing VeriSilicon (688521.SH) today announced that Hefei Hexagon Semiconductor (Hexagon Semi), an image processing SoC provider, has adopted VeriSilicon’s proven IP portfolio in its high-performance HX77 series image processing SoC. The adopted IPs include the GCNanoUltraV 2.5D Graphics Processing Unit (GPU) IP, DW100 DeWarp Processing IP, and DC9200Nano Display Processing IP. The SoC has successfully taped out, achieving a first-pass silicon success. The HX77 series is a highly integrated, low-power image processing SoC based on RISC-V architecture, integrating comprehensive video input/output interfaces, image processing, and system control capabilities. By leveraging an innovative heterogeneous computing architecture and sophisticated power management technology, HX77 has successfully achieved a technological breakthrough that enables 2K@60fps output with
Operio Group Named Distributor for Schaefer Technologies in the United Kingdom and European Union9.3.2026 22:00:00 CET | Press release
Operio Group has signed a distribution agreement with Schaefer Technologies, a manufacturer of semi-automatic encapsulation equipment. Operio Group, a holding company building a global group of brands serving the solid dose manufacturing industry, will be the official distributor of Schaefer Technologies’ products in the United Kingdom and the European Union. Schaefer Technologies develops semi-automatic capsule filling systems, including equipment that produces banded capsules for liquid and pellet formulations used by nutraceutical and pharmaceutical manufacturers. Leadership from both companies worked together to establish the agreement, including Kevin Schaefer, CEO of Schaefer Technologies Inc., and Alastair Sanderson, Chief Business Development Officer at Operio Group. “Schaefer Technologies is looking forward to our new relationship with Operio Group,” said Schaefer. “Their understanding of the pharmaceutical equipment market makes them a strong partner as we combine our experti
Kinaxis Goes All-In on Innovation at Upcoming Kinexions in Las Vegas9.3.2026 19:00:00 CET | Press release
Annual customer conference will bring together global supply chain leaders to explore the latest trends, best practices and technologies in AI-powered planning, decision-making and agentic innovation Registration is officially open for Kinexions North America, the premier global supply chain orchestration conference hosted by Kinaxis® Inc. (TSX: KXS). Taking place June 1–3 in Las Vegas, Nevada, the event brings together supply chain leaders, innovators and practitioners from around the world to explore how organizations can leverage AI-driven strategies and technologies to connect data, people and decisions. After a year defined by market volatility, geopolitical risk and disruption, this year’s conference will focus on how intelligent supply chain orchestration enables organizations to move beyond reactive planning to building true enterprise adaptability. The program promises to be the most immersive and future-forward Kinexions yet, with renowned author, entrepreneur and innovation
InterSystems Appoints Former NHS and Mass General Leader Dr. Tim Ferris as Vice President, Healthcare Practice9.3.2026 17:00:00 CET | Press release
InterSystems, a creative data technology provider powering more than one billion health records globally, today announced the appointment of Tim Ferris, M.D., as Vice President, Healthcare Practice. The announcement comes as healthcare leaders gather for the 2026 HIMSS Global Health Conference & Exhibition. In this role, Dr. Ferris will leverage his comprehensive view of the industry to help drive the clinical and strategic direction of the company’s healthcare solutions worldwide. Drawing on his vast experience, he will serve as a strategic advisor to global health systems and governments, engineer targeted technology solutions based on real-world executive needs, advance his academic research on health data architecture and lead public discourse on the intersection of AI and care delivery. Dr. Ferris brings a unique global perspective to InterSystems that is virtually unmatched in healthcare. His career spans 30 years as a practicing primary care physician, executive leadership at pr
Radial Selects Riskified to Power Payment Fraud and Refund/Return Protection for Merchant Client Portfolio9.3.2026 15:00:00 CET | Press release
The partnership brings Riskified’s AI-powered platform for payment fraud, refund claim, and return abuse protection to Radial’s global network of merchants Riskified (NYSE: RSKD), a leader in ecommerce fraud and risk intelligence, today announced a strategic partnership with Radial, a leading 3PL set to become Paxon later this year. Radial will integrate with Riskified’s AI-powered platform to help its merchants approve more legitimate orders and reduce losses from payment fraud, including many merchants that use Shopify as their ecommerce platform. Radial supports many of the world’s most recognized retail brands with a global ecommerce fulfillment network of more than 20 centers across North America, helping merchants deliver orders quickly and cost effectively. By bringing Riskified’s AI-powered fraud decisioning into its commerce ecosystem, Radial gives merchants the surgical ability to calibrate the checkout experience according to risk—without slowing fulfillment. This also suppo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
